국가: 오스트레일리아
언어: 영어
출처: Department of Health (Therapeutic Goods Administration)
indapamide hemihydrate,perindopril erbumine
Apotex Pty Ltd
indapamide hemihydrate,Perindopril erbumine
Registered
GENRX PERINDOPRIL/INDAPAMIDE 4/1.25 TABLETS 1 GENRX PERINDOPRIL/INDAPAMIDE 4/1.25 TABLETS _Contains the active ingredients perindopril erbumine and indapamide hemihydrate _ CONSUMER MEDICINE INFORMATION _FOR A COPY OF A LARGE PRINT LEAFLET, PH: 1800 195 055 _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about this medicine. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT THIS MEDICINE IS USED FOR The name of your medicine is GenRx Perindopril/ Indapamide 4/1.25 tablets. It contains the active ingredients perindopril and indapamide, which are used to treat high blood pressure (also known as hypertension). Everyone has blood pressure. This pressure helps to circulate blood all around the body. Your blood pressure may be different at different times of the day, depending on how busy or stressed you are. You have high blood pressure (hypertension) when your blood pressure stays higher than is needed, even when you are calm and relaxed. If high blood pressure is not treated, it can lead to serious health problems. You may feel fine and have no symptoms, but eventually it can cause stroke, heart disease and kidney failure. Perindopril/indapamide helps to lower your blood pressure ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed this medicine for another reason. This medicine is available only with a doctor's prescription. There is no evidence that this medicine is addictive. _USE IN OLDER PEOPLE OR _ _CHILDREN _ Elderly people can generally use Perindopril/Indapamide 4/1.25 safely. However, some older people have reduced kidney function - in wh 전체 문서 읽기
1 AUSTRALIAN PRODUCT INFORMATION GENRX PERINDOPRIL/INDAPAMIDE 4/1.25 (PERINDOPRIL ERBUMINE / INDAPAMIDE HEMIHYDRATE) TABLETS 1 NAME OF THE MEDICINE Perindopril erbumine / indapamide hemihydrate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains perindopril erbumine 4 mg and indapamide hemihydrate 1.25 mg, as the active ingredients. EXCIPIENTS WITH KNOWN EFFECT Lactose For the full list of excipients see section 6.1 LIST OF EXCIPIENTS 3 PHARMACEUTICAL FORM White, capsule-shaped, biconvex tablets, engraved "4/1.25" on one side and "APO" on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of hypertension. Treatment should not be initiated with this combination. 4.2 DOSE AND METHOD OF ADMINISTRATION Perindopril/Indapamide 4 /1.25 tablets are intended for oral administration. DOSAGE One Perindopril/Indapamide 4/1.25 tablet per day as a single dose, preferably to be taken in the morning. RENAL IMPAIRMENT In cases of severe renal insufficiency (creatinine clearance below 30 mL/min), the treatment is contraindicated. In patients with moderate renal insufficiency (creatinine clearance from 30 to 60 mL/min), the maximum dose should be at a low dose or with one component. In patients with a creatinine clearance greater than 60 mL/min, no dose adaptation is required. Normal medical practice includes periodic control for creatinine and potassium. HEPATIC IMPAIRMENT In severe hepatic impairment, treatment is contraindicated. 2 In patients with moderate hepatic impairment, no dose modification is required. ELDERLY PATIENTS Renal insufficiency is commonly observed in elderly people. Care should therefore be taken when prescribing perindopril-containing medicines to elderly hypertensive patients The initial daily dose in the elderly should always be at a low dose or with one component only, and patients should be monitored closely during the initial stages of treatment. Particular care should be taken in elderly patients with congestive heart failure who have renal and/or hepatic insuffici 전체 문서 읽기